154 related articles for article (PubMed ID: 19401497)
1. Mechanisms of growth inhibition in human papillomavirus positive and negative cervical cancer cells by the chloromethyl ketone protease inhibitor, succinyl-alanine-alanine-proline-phenylalanine chloromethyl ketone.
Duncan KJ; Eckert KA; Clawson GA
J Pharmacol Exp Ther; 2009 Jul; 330(1):359-66. PubMed ID: 19401497
[TBL] [Abstract][Full Text] [Related]
2. A protease inhibitor specifically inhibits growth of HPV-infected keratinocytes.
Drubin DA; McLaughlin-Drubin ME; Clawson GA; Meyers C
Mol Ther; 2006 Jun; 13(6):1142-8. PubMed ID: 16564747
[TBL] [Abstract][Full Text] [Related]
3. The chloromethylketone protease inhibitor AAPF(CMK) also targets ATP-dependent helicases and SAP-domain proteins.
Dhamne C; Drubin DA; Duncan K; Tevethia MJ; Clawson GA
J Cell Biochem; 2007 Feb; 100(3):716-26. PubMed ID: 17006953
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
Girón RA; Montaño LF; Escobar ML; López-Marure R
FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells.
Borutinskaite VV; Navakauskiene R; Magnusson KE
Ann N Y Acad Sci; 2006 Dec; 1091():346-55. PubMed ID: 17341627
[TBL] [Abstract][Full Text] [Related]
7. The serine protease inhibitors TLCK and TPCK inhibit the in vitro immortalization of primary human keratinocytes by HPV-18 DNA.
Stöppler H; Koval D; Schlegel R
Oncogene; 1996 Oct; 13(7):1545-8. PubMed ID: 8875993
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid inhibits cell growth in HPV negative cervical carcinoma cells by induction of insulin-like growth factor binding protein-5 (IGFBP-5) secretion.
Higo H; Duan C; Clemmons DR; Herman B
Biochem Biophys Res Commun; 1997 Oct; 239(3):706-9. PubMed ID: 9367833
[TBL] [Abstract][Full Text] [Related]
9. Effect of 4-hydroxyphenylretinamide on human cervical epithelial and cancer cell lines.
Zou C; Vlastos AT; Yang Li; Wang J; Brewer M; Follen M
J Soc Gynecol Investig; 2003 Jan; 10(1):41-8. PubMed ID: 12517593
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and application of MeOSuc-Ala-Ala-Pro-Phe-CH2Cl as potent proteinase K inhibitor.
Kore AR; Shanmugasundaram M; Hoang Q; Kuo M; Chapman LM; Chen HH
Bioorg Med Chem Lett; 2009 Mar; 19(5):1296-300. PubMed ID: 19211247
[TBL] [Abstract][Full Text] [Related]
11. Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle.
Bernard B; Fest T; Prétet JL; Mougin C
Cell Death Differ; 2001 Mar; 8(3):234-44. PubMed ID: 11319606
[TBL] [Abstract][Full Text] [Related]
12. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
Hampson L; Kitchener HC; Hampson IN
Antivir Ther; 2006; 11(6):813-25. PubMed ID: 17310826
[TBL] [Abstract][Full Text] [Related]
13. N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) suppresses neuritic degeneration caused by different experimental paradigms including in vitro Wallerian degeneration.
Ikegami K; Kato S; Koike T
Brain Res; 2004 Dec; 1030(1):81-93. PubMed ID: 15567340
[TBL] [Abstract][Full Text] [Related]
14. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability.
Stöppler H; Stöppler MC; Adduci A; Koval D; Schlegel R
Virology; 1996 Mar; 217(2):542-53. PubMed ID: 8610446
[TBL] [Abstract][Full Text] [Related]
15. High and low molecular weight DNA cleavage in ovarian granulosa cells: characterization and protease modulation in intact cells and in cell-free nuclear autodigestion assays.
Trbovich AM; Hughes FM; Perez GI; Kugu K; Tilly KI; Cidlowski JA; Tilly JL
Cell Death Differ; 1998 Jan; 5(1):38-49. PubMed ID: 10200444
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis.
Seagon S; Dürst M
Cancer Res; 1994 Nov; 54(21):5593-8. PubMed ID: 7923202
[TBL] [Abstract][Full Text] [Related]
17. The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts.
Deberne M; Levy A; Mondini M; Dessen P; Vivet S; Supiramaniam A; Vozenin MC; Deutsch E
Anticancer Drugs; 2013 Jul; 24(6):599-608. PubMed ID: 23698251
[TBL] [Abstract][Full Text] [Related]
18. Activation of chymotrypsin-like serine protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor.
Grabarek J; Dragan M; Lee BW; Johnson GL; Darzynkiewicz Z
Int J Oncol; 2002 Feb; 20(2):225-33. PubMed ID: 11788882
[TBL] [Abstract][Full Text] [Related]
19. Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells.
Qiao Y; Cao J; Xie L; Shi X
Arch Pharm Res; 2009 Sep; 32(9):1309-15. PubMed ID: 19784588
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy.
García-Zepeda SP; García-Villa E; Díaz-Chávez J; Hernández-Pando R; Gariglio P
Eur J Cancer Prev; 2013 Nov; 22(6):577-84. PubMed ID: 23603746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
